Prof. MUDr. Aleksi Šedo, DrSc.
Principal investigator of the project and Director of the National Institute for Cancer Research
Head of the Prague hub
Head of research programme Molecular Foundation of Cancers and Molecular Goals
Home institution: First Faculty of Medicine of the Charles University
Aleksi Šedo is head of the Institute of Biochemistry and Experimental Oncology of the First Faculty of Medicine and head of one of the programmes of the Centre for Tumour Ecology, which is an Operational Programme for Research, Development, and Education co-financed by the EU. He works mainly in applied biomedical research focused on the regulation and signaling of cell proliferation and differentiation and on innovative goals in the diagnostics and therapy of tumours. He is the author of numerous studies, patents, and dozens of scientific publications. Šedo is an internationally respected scientist especially in the field of study of proteases and of the microenvironment of malignant glioblastomas. In 2012–2020, he served as Dean of the First Faculty of Medicine, earlier was a visiting professor in Pisa, researcher at the Institut Curie in Paris, and a senior scientist in research and development at the Procter & Gamble centre in Frankfurt am Main. He is a member of the Scientific Board of the Ministry of Health of the Czech Republic, member of the board of the Czech Health Research Council, of the Masaryk Memorial Cancer Institute, and the founding head of the Neurooncology Section of the Czech Society for Oncology (under the Czech Medical Association of Jan Evangelista Purkyně), and member of the Czech Medical Academy.
Prof. RNDr. Ondřej Slabý, Ph.D.
Scientific Director of the National Institute for Cancer Research
Head of the Brno hub
Head of research programme Biomarkers of Cancers and Diagnostics of Cancers
Home institution: Faculty of Medicine and Central European Institute of Technology (CEITEC) of the Masaryk University
Ondřej Slabý is head of the Department of Biology of the Faculty of Medicine of Masaryk University, head of research group CEITEC of the Masaryk University, and Scientific Secretary of Masaryk Memorial Cancer Institute. He is active in biomedical research focused on tumour genomics and in the study of non-coding RNA. Slabý is the author of over two hundreds scientific publications which had been cited over 7,000 times and holder of several international patents. He specialisases in clinical genetics and is a pioneer of the concept of precision oncology in the Czech Republic. Since 2018, Slabý serves as head of the Czech-Slovak Society for Biology. In 2020–2021, he served as government’s deputy for science and research and is currently an advisor of the Minister of Health for science and research. Slabý is head of the board of the Czech Health Research Council since Febuary 2023. Slabý also focuses on several scientific and area boards and the holder of several awards (e.g., the Award of the Czech Medical Association of Jan Evangelista Purkyně or the Award of the Minister of Health of the Czech Republic). His international experience includes a visiting professorship at the Rockefeller University in New York.
Doc. MUDr. Marián Hajdúch, Ph.D.
Marián Hajdúch is the founding director of the Institute of Molecular and Translational Medicine of the Faculty of Medicine of Palacký University and director of EATRIS-CZ, which is Czech national hub of the European Infrastructure for Translational Medicine. He is active mainly in translational but also basic research with focus on the molecular foundation of tumours and infectious diseases, identification of new biomarkers, therapeutic goals, and new pharmaceuticals. He is the founder of personalised medicine in the Czech Republic. Hajdúch served as national coordinator of testing during the Covid-19 pandemic. He is the author of dozens of scientific publications and holder of over 40 pharmaceutical patents. He currently serves as member of Science, Research, and Innovation Council, is head of its Bioethics Committee, vice-president of the Cancer Research Foundation, and member of the steering committee of Early Cancer Detection Europe. For twelve years, he participated in the management of European Infrastructure for Translational Medicine EATRIS-ERIC.
Board of the National Institute for Cancer Research
- prof. MUDr. Aleksi Šedo, DrSc., 1. lékařská fakulta Univerzity Karlovy
- prof. RNDr. Ondřej Slabý, Ph.D., Lékařská fakulta a CEITEC Masarykovy Univerzity
- doc. MUDr. Marián Hajdúch, Ph.D., Lékařská fakulta Univerzity Palackého
- MUDr. Ludmila Boublíková, Ph.D., 1. lékařská fakulta Univerzity Karlovy
- MUDr. Petr Džubák, Ph.D., Lékařská fakulta Univerzity Palackého
- prof. Ing. Michal Hocek, CSc., DSc., Ústav organické chemie a biochemie AV ČR
- prof. MUDr. Pavel Klener, Ph.D., 1. lékařská fakulta Univerzity Karlovy
- prof. MUDr. Karel Smetana, DrSc., 1. lékařská fakulta Univerzity Karlovy
- prof. MUDr. Marek Svoboda, Ph.D., Masarykův onkologický ústav
- prof. MUDr. Jan Trka, Ph.D., 2. lékařská fakulta Univerzity Karlovy